Treatment of Sorafav 200mg: Effective Relief

Sorafav 200mg Tablet

Uses:

• Advanced renal cell carcinoma;
• Advanced hepatocellular carcinoma that cannot be surgically treated;
• Advanced papillary and follicular Hurtle cell thyroid carcinoma.

Mechanism of action:

• Inhibits multiple receptor tyrosine kinases (enzymes), primarily vascular endothelial growth factor receptors and platelet-derived growth factor-β receptors;
• Prevents the development of blood vessels in tumor cells (angiogenesis);
• Arrests the growth and spread of tumor cells to other organs.

Important information:

• Store below 30°C in a dry place;
• Take the tablet without food (1 hour before or 2 hours after a meal);
• Swallow with a glass of water;
• Do not break, crush or chew the tablets.

Safety advice:

• Pregnancy: it is unsafe to use during pregnancy as it may harm the unborn baby;
• Breastfeeding: do not breastfeed during treatment and for two weeks after the last dose;
• Lungs: cautiously administered in patients with certain lung problems;
• Liver: take with caution in patients with severe liver disease;
• Alcohol: avoid drinking alcohol while taking the tablet;
• Driving: avoid driving or doing things that require focus during treatment.

Side effects:

• Serious: Stevens-Johnson syndrome and toxic epidermal necrosis, decreased blood flow to the heart, increased risk of bleeding, high blood pressure, skin problems, liver problems, problems in wound healing;
• Common: nausea, stomach pain, diarrhea, tiredness and weakness, infection, hair thinning and patchy hair loss, rash, weight loss, loss of appetite, low levels of calcium in the blood, flu-like illness.

FAQ:

• Can a diabetic person take Sorafav 200mg Tablet? Yes, but only after seeing a doctor.
• What are the conditions under which Sorafav 200mg Tablet use is prohibited? Sorafav 200mg Tablet is not recommended for people who are allergic to any of its ingredients, have squamous cell lung cancer, or are already taking carboplatin and paclitaxel.
• When should I stop taking Sorafav 200mg Tablet as a treatment? Sorafav 200mg Tablet should be discontinued if a person experiences a major adverse effect that impairs their quality of life.
• What class of medication is Sorafav 200mg Tablet? Sorafav 200mg Tablet belongs to the group of medicines called anti-tumor and tyrosine kinase inhibitors.
• I am pregnant. Can I use Sorafav 200mg Tablet during pregnancy? Sorafav 200mg Tablet should not be taken during pregnancy as it may harm the unborn baby.

Fact box:

• Molecule name: Sorafenib;
• Therapeutic class: Tyrosine kinase inhibitor;
• Pharmacological class: Anti-Neoplastics.

Tags: Sorafav, Tablet, 200mg, Medicament, Health, Medicine, Drug, Pharmacy